December - 2015
| Previous Next | Showing Journal 3 of 7 |
A Multicenter Randomized Trial of Continuous versus Intermittent B-Lactam Infusion in Severe SepsisJ Delahunty, J Roberts, J Davis, et al for the BLING II Investigators for the ANZICS Clinical Trials Group Am J Resp Crit Care Med, 2015, 192 (11); 1298-1305 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
December |
Previous Comments
No Comments yet.
Comment
The traditional administration of B-lactams in critical illness is by intermittent dosing. However the time-dependence of antibacterial activity, and animal and in vitro evidence of better bacterial killing through continuous infusion, has led to the...